Genkyotex Annonce Les Résultats Favorables de L’analyse Post-Hoc de L’essai de Phase 2 Dans la CBP et Publie sa Situation de Trésorerie au 30 Juin 2019

NEXT STORY
Curetis to Present at Solebury Trout European Biotech Investor Day in NYC
PREV STORY
Roxadustat China Phase 3 Trial for Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine (NEJM)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ASN Kidney Week 2018: Data Presented from Two Japanese Phase 3 Studies on Roxadustat in the Treatment of Anemia Associated with Chronic Kidney Disease in Patients on Dialysis

TOKYO and SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Astellas Pharma Inc. (TSE: ...

author_avatar
NASDAQ Market News

Outlook on the mRNA Global Market and Therapeutics to 2026

author_avatar
NASDAQ Market News

Aileron Therapeutics Presents Data at AACR-NCI-EORTC International Conference Demonstrating ALRN-6924’s Activity as Radioprotective Agent in Preclinical Models of Acute Radiation-Induced Toxicity

author_avatar
NASDAQ Market News